82 results about "Diminution" patented technology

The present invention is directed to therapeutic compounds, treatment methods, and kits affecting the NCCa-ATP channel of neural tissue, including neurons, glia and blood vessels within the nervous system, and methods of using same. The NCCa-ATP channel is newly expressed in neural tissue following injury such as ischemia, and is regulated by the sulfonylurea receptor SUR1, being inhibited by sulfonylurea compounds, e.g., glibenclamide and tolbutamide, and opened by diazoxide. Antagonists of the NCCa-ATP channel, including SUR1 antagonists, are useful in the prevention, diminution, and treatment of injured or diseased neural tissue, including astrocytes, neurons and capillary endothelial cells, that is due to ischemia, tissue trauma, brain swelling and increased tissue pressure, or other forms of brain or spinal cord disease or injury. Agonists of the NCCa-ATP channel may be are useful in the treatment neural tissue where damage or destruction of the tissue, such as a gliotic capsule, is desired.

The present invention is directed to a combination of therapeutic compounds and treatment methods and kits using the combination. In particular, one of the combination affects the NCca-ATP channel of neural tissue, including neurons, glia and blood vessels within the nervous system. Exemplary SUR1 and / or TRPM4 antagonists that inhibit the NCca-ATP channel may be employed in the combination. The combination therapy also employs one or more of a non-selective cation channel blocker and / or an antagonist of VEFG, NOS, MMP, or thrombin. Exemplary indications for the combination therapy includes the prevention, diminution, and / or treatment of injured or diseased neural tissue, including astrocytes, neurons and capillary endothelial cells, that is due to ischemia, tissue trauma, brain swelling and increased tissue pressure, or other forms of brain or spinal cord disease or injury, for example. In other embodiments, there are methods and compositions directed to antagonists of TRPM4, including at least for therapeutic treatment of traumatic brain injury, cerebral ischemia, central nervous system (CNS) damage, peripheral nervous system (PNS) damage, cerebral hypoxia, or edema, for example.

A stereotactic breast biopsy apparatus and system that may comprise an x-ray source, a digital imaging receptor, and a biopsy specimen cassette, wherein the x-ray source is provided with a means for displacing the beam axis of the x-ray source from a working biopsy corridor beam axis to permit an unobstructed illumination of the biopsy specimen and thereby produce biopsy x-ray images directly in the procedure room for immediate analysis. Some examples of the benefits may be, but are not limited to, a more rapid analysis of biopsy specimen digital images, post-processing image capability, and decreased procedure time and diminution of patient bleeding complications and needle discomfort.

A stereotactic breast biopsy apparatus and system that may comprise an x-ray source, a digital imaging receptor, and a biopsy specimen cassette, wherein the digital imaging receptor is adjustably secured to the apparatus to permit an unobstructed illumination of the biopsy specimen and thereby produce biopsy x-ray images directly in the procedure room for immediate analysis. Some examples of the benefits may be, but are not limited to, a more rapid analysis of biopsy specimen digital images, post-processing image capability, and decreased procedure time and diminution of patient bleeding complications and needle discomfort.

A stereotactic breast biopsy apparatus and system that may comprise an x-ray source, a digital imaging receptor, and a biopsy specimen cassette, wherein the x-ray source is provided with a means for displacing the beam axis of the x-ray source from a working biopsy corridor beam axis to permit an unobstructed illumination of the biopsy specimen and thereby produce biopsy x-ray images directly in the procedure room for immediate analysis. Some examples of the benefits may be, but are not limited to, a more rapid analysis of biopsy specimen digital images, post-processing image capability, and decreased procedure time and diminution of patient bleeding complications and needle discomfort.

The current invention relates to an adjustable mandibular advancement device with a unique combination of resilient hinging and adjustability to prevent or reduce snoring and / or obstructive sleep apnea syndrome. The adjustability is described by means of two concepts of adjustability for the relative enlargement or diminution of the members of the device, incremental and successive advancement mechanisms, in either combination or separately. By use of thermoplastic materials the device can be used in the outmost variability of the human dentition.

The invention discloses a beef ball which comprises main materials and auxiliary materials, wherein the main materials comprise the following components in parts by weight: 20-30 parts of beef, 2-4 parts of starch, 4-6 parts of soy isolate protein, 10-12 parts of icy water, 3-5 parts of chicken breast meat and 1-2 parts of egg liquid; the auxiliary materials are added according to the percentage of the weight of the main materials; the auxiliary materials comprise the following components in percentage by weight of the main materials: 0.5-2% of salt, 1-2.5% of sugar, 0.2-0.6% of aginomoto, 1-1.5% of fried shallot, 0.05-0.1% of beef flavor, 2-3% of soybean sauce and 1-2% of lycium barbarum. The beef ball is rich in nutrition and rich in protein, vitamin and microelement; the nutrient components of the livestock and poultry meat complement with one another; the skin is soft, crispy, very chewable, thick in fragrance and fragrant, tender and tasty; due to the adoption of lycium barbarum, the beef ball has the functions of nourishing the kidney and strengthening the essence, nourishing the liver to brighten the eye and moistening lung to arrest cough, and has a good tonifying function for people with blood and qi deficiency, weak constitution, vision diminution, anemia, chronic hepatitis, toxic or metabolism liver diseases and biliary system diseases.

Disclosed is a Chinese proprietary medicine wherein the raw materials mainly include tuber of multiflower knotweed and other Chinese medicinal herbs. The medicament can be used for treating nervous prostration, pseudomyopia, diminution of vision, vision fatigue, abnormal menstruation, hypertension, hyperlipemia and alopecia.

A system is demonstrated which captures carbon dioxide from the atmosphere by introducing air into the vehicle at high speeds and reacting such air with hydroxide-containing material. System comprises means for introducing air into vehicle, means for reacting the air in reaction vessels and means for stopping the carbon dioxide scrubbing once a predetermined carbonate concentration is reached in the solution.

A stereotactic breast biopsy apparatus and system that may comprise an x-ray source, a digital imaging receptor, and a biopsy specimen cassette, wherein the digital imaging receptor is adjustably secured to the apparatus to permit an unobstructed illumination of the biopsy specimen and thereby produce biopsy x-ray images directly in the procedure room for immediate analysis. Some examples of the benefits may be, but are not limited to, a more rapid analysis of biopsy specimen digital images, post-processing image capability, and decreased procedure time and diminution of patient bleeding complications and needle discomfort.

The current invention relates to an adjustable mandibular advancement device with a unique combination of resilient hinging and adjustability to prevent or reduce snoring and / or obstructive sleep apnea syndrome. The adjustability is described by means of two concepts of adjustability for the relative enlargement or diminution of the members of the device, incremental and successive advancement mechanisms, in either combination or separately. By use of thermoplastic materials the device can be used in the outmost variability of the human dentition.

The invention relates to an intelligent desk for correcting a sitting posture. The intelligent desk comprises a desktop, desk legs, an infrared emitter, an infrared camera, a visible light camera, a control box and a display panel, wherein a reading-writing area is arranged on the desktop; the infrared emitter is used for projecting infrared structured light; the infrared camera is used for collecting an infrared structured light image; the visible light camera is used for collecting a sitting posture image of a human body; the display panel is used for displaying the sitting posture; the infrared camera and the visible light camera respectively transmit the collected image into the control box for image processing; after infrared structured light measurement, three-dimensional reconstruction and object recognition, the sitting posture image information of a user is analyzed; finally, the sitting posture image information is sent to the display panel. The invention also provides a method for correcting the sitting posture based on the intelligent desk. According to the intelligent desk and the correction method thereof, the correction of the sitting posture is realized by using an information technique and an image modeling processing technique; not only is no discomfort caused to the user, but also the sitting posture of people can be effectively and precisely corrected; therefore the vision diminution resulting from an incorrect sitting posture is avoided.

The invention relates to an eye drop used for releasing eye fatigue and a preparation method thereof. The eye drop comprises following raw materials: radix rehmanniae, rhizoma atractylodis, crab grass, serissa japonica, jasmine, red-spotted stonecrop, wolfberry, astragalus smicus, python gall, cocklebur, chamomile, concha haliotidis, Taiwan beautyberry, globe amaranth, pearl and weathered sodium sulfate powder. The eye drop is a pure traditional Chinese medicine preparation; is prepared by modern advanced pharmaceutical technologies; has efficacies of clearing away heat and purging pathogenic fire, relieving spasm and removing eyewinker, and nourishing the liver and improving visual acuity; and can be used for treating diminution of vision and pseudomyopia of teenagers, and reliving visual fatigue of eyes, and symptoms caused by visual fatigue such as conjunctival injection and eye itch. Compatibility of the selected raw materials is appropriate, curative effects are significant, safety performance is excellent, no side effects exist, cost is low, and the eye drop is worth of wide popularization and application.

The invention provides an eyeball training system and method. The system comprises a display module, a depth camera module and a processing module, wherein the display module is used for displaying the eyeball training content, the depth camera module is used for obtaining human-face images of a user in real time, and the processing module is used for receiving and processing the human-face imagesand obtaining human-face orientation data and eyeball motion trajectory data of the user; eyeball training of the user is evaluated according to preset eyeball training evaluating indexes, and the human-face orientation data and the eyeball motion trajectory data of the user. Based on the human-face orientation data and the eyeball motion trajectory data, the processing module measures the eyeball training effect of the user according to the preset eyeball training evaluating indexes; aiming at the eyeball training effect of the user, relevant training suggestions and guidance are timely given, the situation that the user is harmed due to incorrect operation is prevented, convenience is brought for the user to more reasonably and scientifically exercise the eye muscle group, and the purpose of preventing or relieving the vision diminution of the user is achieved.

A neuroprotective composition for protecting neuronal cells against oxidative stress and methods for using and preparing the same. More particularly, the neuroprotective composition of the invention comprises a therapeutically effective amount of ceruloplasmin or a functional derivative thereof. The neuroprotective composition is characterized in that it protects neuronal cells from reactive oxygen species such as .O2- and .OH. In a preferred embodiment, the neuroprotective composition further comprises an antioxidant consisting of catalase or of an amphiphilic physiological antioxidative solution comprising a mixture of pyruvate, antioxidant, and lipid(s) such as fatty acids. The neuroprotective composition could be used for the treatment of brain trauma, brain or cerebrovascular ischemia, neurodegenerative diseases, poisoning of neuronal cells, the diminution of drugs side effects and for preservation of neuronal grafts.

The invention discloses a system of waterpower cavitation enhanced supercritical assistant pulverization preparing particle and a method thereof, which has the following character that: (1) sieve plate is mounted in the waterpower cavitation mixer to form cavity, inanition and cavum in the miscible liquid flow of supercritical CO2 and solution to realize the rapid mixture thereof, and to make the meltage of the supercritical CO2 in the solution approach the equilibrium solubility; (2) the mixture of the supercritical CO2 and solution is sprinkled into the precipitator by nozzle to form secondary liquid drop, which is heat transfer and mass transfer with N2 to make the liquid vaporize, and then get particle; (3) the particle is collected using the sintered plate mounted on the bottom of the precipitator; (4) the mixing gas of CO2, N2 and solvent enter into the condenser, and the solvent is reclaimed and recycling. The operating condition of the invention is relative mildness, the operating process is simple, the residual of the solvent is low, and the size distribution of the product is narrow. The invention can be used for grain diminution of various of material.

A laminated body includes: a porous base material containing a polyolefin-based resin as a main component; and a porous layer which is disposed on at least one surface of the porous base material and which contains a polyvinylidene fluoride-based resin, the laminated body being arranged so that: a diminution rate of diethyl carbonate dropped on the porous base material is 15 sec / mg to 21 sec / mg; a spot diameter of the diethyl carbonate 10 seconds after the diethyl carbonate was dropped on the porous base material is not less than 20 mm; and the polyvinylidene fluoride-based resin containing crystal form α in an amount of not less than 36 mol % with respect to 100 mol % of a total amount of the crystal form α and crystal form β contained in the polyvinylidene fluoride-based resin. A nonaqueous electrolyte secondary battery separator made of the laminated body is not easily curled.

The invention discloses a dendrobium officinale oculentum for relieving asthenopia, and relates to the field of eye health products. The dendrobium officinale oculentum for relieving asthenopia comprises the following raw materials in parts by weight: 30 to 50 parts of dendrobium officinale, 25 to 40 parts of fructus Lycii, 20 to 40 parts of semen cassiae, 20 to 40 parts of baical skullcap root, 20 to 40 parts of semen celosiae, 15 to 30 parts of semen plantaginis, 15 to 30 parts of peppermint, 15 to 30 parts of prunella vulgaris, 1500 to 3000 parts of oculentum substrate and a proper amount of water. The oculentum adopts a reasonable Chinese herbal medicine combination manner, realizes the pharmacological functions of eye pathological change prevention, vision diminution resistance and eye dryness relieving, and achieves the purpose of relieving asthenopia.

The invention disclosed is a method for decreasing the internal resistance or impedance of a battery or electrochemical cell is described which comprises the step of discharging the battery or cell until it reaches an overdischarge condition and maintaining the battery or cell in the overdischarge condition for a period of time sufficient to effect a diminution of the internal resistance or impedance of a battery or electrochemical cell; and a battery or electrochemical cell having a reduced impedance.

The invention discloses a display control method. The invention discloses a terminal and a computer readable storage medium. The objective of the invention is to solve a problem that when a terminal display screen outputs display information to a user, eye fatigues and diminution of vision of the user can be easily caused. The embodiment of the invention provides a display control scheme. When itis determined that an eye protection display mode needs to be entered; detecting an object viewing distance between a viewing object and a terminal display screen; determining a scaling ratio under the current visual object distance according to a mapping relation between the visual object distance and the scaling ratio of the display object; the display size of the display object on the display background is adjusted according to the determined scaling ratio; Therefore, the display size of the display object is matched with the object viewing distance between the viewing object and the display screen, the problem that the ideal object viewing distance cannot be correctly kept due to the poor object viewing habit of the viewing object and consequently the burden of eyes is intensified is avoided, the eyesight of a user is effectively protected under the condition that the user views the screen for a long time, and the user experience is improved.

A neuroprotective composition for protecting neuronal cells against oxidative stress and methods for using and preparing the same. More particularly, the neuroprotective composition of the invention comprises a mixture of pyruvate, antioxidant, and lipid(s) such as fatty acids. The neuroprotective composition could be used for the treatment of brain trauma, brain or cerebrovascular ischemia, neurodegenerative diseases, poisoning of neuronal cells, the diminution of drugs side effects and for preservation of neuronal grafts.

The present invention relates to dietotherapy technology with Chinese medicine in treating eye diseases, including conjunctive congestion with swelling and pain, night blindness and diminution of vision. The therapeutic food is produced with burrerfly bush flower, chrysanthemum, pipewort, abalone shell, millet, honey and water in certain weight proportion. It has functions of invigorating spleen, whetting appetite, clearing away liver fire to treat eye disease, and dispelling wind and heat, and is favorable to treating said eye diseases.

An object of the present invention is to provide a pharmaceutical agent or composition useful as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction, motor paralysis, diminution of vision, hepatitis, inflammatory intestinal syndrome, functional enteropathy, functional cardiopathy, functional hepatopathy, functional nephropathy, dementia, climacteric symptoms, senile dementia and / or Alzheimer disease, and a dermatological agent or composition suitable for skin applications, which can treat or prevent muscle weakening and inflammation, in particular arthritis, by its muscle-strengthening and / or anti-inflammatory actions, said agent or composition comprising isoflavone and / or isoflavone glycoside in combination with a pungent substance, a bitter substance or a sour substance, and cholic acid, and / or scymnol and / or a scymnol ester. The present invention relates to an agent or composition usuful as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction, motor paralysis, diminution of vision, hepatitis, inflammatory intestinal syndrome, functional enteropathy, functional cardiopathy, functional hepatopathy, functional nephropathy, dementia, climacteric symptoms, senile dementia and / or Alzheimer disease, and / or an agent or composition to be applied to the skin, said agent or composition comprising isoflavone and / or isoflavone glycoside in combination with a pungent substance, a bitter substance or a sour substance, and cholic acid, and / or scymnol and / or a scymnol ester.

The invention discloses a Chinese medicine preparation, comprising following raw materials by weight: 6.7-15.0 portions of tuber fleeceflower root, 8.4-19.0 portions of Chinese yam rhizome, 6.7-15.0 portions of hedge prinsepia nut flesh, 5.1-11.6 portions of black bean coat, 6.7-15.0 portions of burrerfly bush flower, 3.9-8.8 portions of anemarrhena, 6.7-15.0 portions of dwarf lilyturf tuber, 6.7-15.0 portions of tribulus terrestris, 2.6-5.8 portions of magnolia vine fruit and 13.3-30.0 portions of radix tangshen. The invention also discloses the application of the Chinese medicine preparation for treating the senile cataract and the diminution of vision, and a preparing method for preparing the Chinese medicine preparation. The invention provides the treatment principle of invigorating the liver and the kidney and benefiting vital energy based on the theory of traditional Chinese medicine to the senile cataract. The medicine can be prepared into conventional oral preparation, such as tablets, granules, capsules, oral liquid, and pills by the conventional method of the Chinese medicine preparation.

The invention provides a lumbar vertebra support device. The lumbar vertebra support device comprises a waist support belt, axilla stabilizing belt assemblies and two sets of same expansion and contraction devices, wherein each set of expansion and contraction device comprises a piston rod, a cylinder barrel, a piston and expansion and contraction springs positioned in the cylinder barrel, the top of each piston rod extends out of each corresponding cylinder barrel and is provided with an axilla support, the bottom of the piston rod is fixed to the upper end surface of the piston, and the top ends of the expansion and contraction springs push against the lower end surface of the piston; the cylinder barrels of the two sets of expansion and contraction devices are respectively connected to the waist support belt, and the axilla supports are connected with the axilla stabilizing belt assemblies. The lumbar vertebra support device can be used for correcting the sitting position of the human body, so that the diminution of vision caused by the too close distance between the eyes and the observed object is avoided, meanwhile, the extrusion from the gravity of the human upper body to the lumbar vertebra is alleviated, so that the stress applied to the lumbar vertebra of the lumbar vertebra patient is alleviated, and the lumbar vertebra support device has the adjuvant therapy and health effects for the lumbar vertebra patient.

A clear aqueous formulation for topical application in the oral cavity of humans to treat leukoplakia contains water, beta-carotene, a water miscible polyol, an unsaturated fatty acid ester, and a surfactant, preferably polyethoxylated castor oil or POE(20) sorbitan monooleate The formulation preferably also contains a pharmaceutically acceptable anti-oxidant, preferably d-alpha-tocopherol (vitamin E), and is in the form of an oral rinse or as a gel well suited for spreading on gums or other parts of the oral cavity. The formulation is applied in a gel form on a substantially regular daily basis to areas in the oral cavity where leukoplakia lesions are present. Persistent application of the gel results in substantial diminution or total elimination of the leukoplakia lesions.